Trial intelligence / Profile preview

Pioglitazone vs Rosiglitazone in Metabolic Syndrome

NCT00314561Phase 4Completed

Sponsor
Korea University Anam Hospital
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone, rosiglitazone in metabolic syndrome, sponsored by Korea University Anam Hospital. Started May 2006; status: completed.

02

Drugs

pioglitazonerosiglitazone
03

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT00314561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00314561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call